Skip to main content
. 1999 Nov;48(5):669–677. doi: 10.1046/j.1365-2125.1999.00090.x

Figure 3.

Figure 3

Observed and population predicted plasma concentrations of 4-hydroxycyclophosphamide vs time in breast cancer patients receiving a 96 h cyclophosphamide infusion (6 g m−2) in combination with thiotepa (500 mg m−2) and carboplatin (800 mg m−2).